Megestrol acetate, 98%, a synthetic progesteronal agent with an IC50 of 260 μM for the inhibition of HegG2

Name: Megestrol acetate, 98%, a synthetic progesteronal agent with an IC50 of 260 μM for the inhibition of HegG2 | 595-33-5
Brand: J&K Chemical
SKU: JK535697_5_G
Price: 151.0 USD
Availability: OutOfStock

Cat. No JK535697_5_G

Vendor: J&K Chemical

Product Information

Product Name

Megestrol acetate, 98%, a synthetic progesteronal agent with an IC50 of 260 μM for the inhibition of HegG2

Brand Name

J&K

Product Number

535697

CAS

595-33-5

SDS Document

View/Download

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

11683

IUPAC Name

(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopentaaphenanthren-17-yl acetate

InChI Key

RQZAXGRLVPAYTJ-GQFGMJRRSA-N

SMILES

CC1=CC@@H2C@H(CCC@3(C@H2CCC@@3(C(=O)C)OC(=O)C)C)C@@4(C1=CC(=O)CC4)C

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Integrative In-silico, Network Pharmacology, Pharmacogenomics and In-vitro Evaluation of Fulvestrant-Loaded Zinc Oxide Nanoparticles Targeting HER2 Positive Breast Cancer

Publication Name: Pharmaceutical Research

Publication Date: 2026-01-08

DOI: 10.1007/s11095-025-03998-x

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial

Publication Name: Nature Cancer

Publication Date: 2026-01-05

DOI: 10.1038/s43018-025-01087-x

A succinylation-related prognostic model for predicting lung adenocarcinoma prognosis and guiding immunotherapy

Publication Name: Clinical Proteomics

Publication Date: 2026-01-03

DOI: 10.1186/s12014-025-09570-4

Fertility Control in Wildlife: Review of Current Status, Including Novel and Future Technologies

Publication Name: Advances in experimental medicine and biology

Publication Date: 2026

DOI: 10.1007/978-3-031-87707-0_18

Hormonal Therapies

Publication Name: Veterinary Psychiatry of the Cat

Publication Date: 2026

DOI: 10.1007/978-3-032-06260-4_26

Megestrol acetate, 98%, a synthetic progesteronal agent with an IC50 of 260 μM for the inhibition of HegG2

Product Information

General Information

Safety Information

References Data Source From Pubchem

Integrative In-silico, Network Pharmacology, Pharmacogenomics and In-vitro Evaluation of Fulvestrant-Loaded Zinc Oxide Nanoparticles Targeting HER2 Positive Breast Cancer

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial

A succinylation-related prognostic model for predicting lung adenocarcinoma prognosis and guiding immunotherapy

Fertility Control in Wildlife: Review of Current Status, Including Novel and Future Technologies

Hormonal Therapies